Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the prevention and management of hepatic veno-occlusive disease (VOD) following hematopoietic stem cell transplantation (HSCT). Additionally, Dr Giralt outlines maintenance therapies, in particular after allogeneic HSCT. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).